COMMITMENTS, CONTINGENCIES, AND CONCENTRATIONS (Details)			3 Months Ended			12 Months Ended
	Mar. 19, 2021 Claim	Jan. 03, 2020 USD ($) shares	Mar. 31, 2022 USD ($) Applicants Claim KeyEmployee	Mar. 31, 2021 USD ($)		Dec. 31, 2020 Lawsuit	Dec. 31, 2021 USD ($)
Concentrations [Abstract]
Net product revenue			$ 18,816,611	$ 8,724,359
Accounts Receivable			$ 9,879,954				$ 11,441,107
Employment Contracts [Abstract]
Number of key employees with whom Company has employment contracts | KeyEmployee			3
Aggregate annual salaries of employment contracts			$ 1,178,000
Contract one, expiration date			Dec. 31, 2022
Contract two expiration date			Dec. 31, 2024
Future minimum salary commitments [Abstract]
2022			$ 883,500
2023			383,000
2024			$ 383,000
Benefit Plan [Abstract]
Percentage of employer's matching contribution			40.00%
Expenses related to matching contribution			$ 67,135	35,456
Components of Lease Expense [Abstract]
Operating lease expense			403,385	408,466
Finance lease cost [Abstract]
Amortization of right-of-use assets			17,579	15,758
Interest on lease liabilities			4,686	4,944
Total finance lease expense			22,265	20,702
Cash paid for amounts included in the measurement of lease liabilities [Abstract]
Operating cash flows for operating leases			360,878	347,871
Operating cash flows for finance leases			4,686	4,944
Financing cash flows for finance leases			16,930	14,282
Right-of-use assets obtained in exchange for lease obligations [Abstract]
Finance leases			16,234	0
Finance Leases [Abstract]
Finance lease right-of-use asset			356,997	315,153
Accumulated depreciation			(166,471)	(97,777)
Finance lease right-of-use asset, net			$ 190,526	$ 217,376			191,870
Weighted Average Remaining Lease Term [Abstract]
Operating leases			7 years 4 months 24 days	8 years 7 months 6 days
Finance leases			2 years 9 months 18 days	3 years 6 months
Weighted Average Discount Rate [Abstract]
Operating leases			9.32%	9.30%
Finance leases			8.56%	8.18%
Maturities of Operating Lease Liabilities [Abstract]
2022			$ 1,086,370	$ 861,916
2023			1,221,017	1,057,757
2024			1,018,875	1,026,272
2025			1,049,442	1,018,875
2026			1,080,925	1,049,442
Thereafter			3,643,521	4,724,446
Total lease payments			9,100,150	9,738,708
Less: imputed interest			2,450,412	2,968,703
Total			6,649,738	6,770,005
Maturities of Finance Lease Liabilities [Abstract]
2022			65,913	57,678
2023			87,884	76,904
2024			60,116	76,904
2025			16,731	49,136
2026			5,940	5,751
Thereafter			355	0
Total lease payments			236,939	266,373
Less: imputed interest			29,781	36,544
Total			$ 207,158	229,829
Stockholder Litigation [Abstract]
Number of class action lawsuits | Lawsuit						4
Number of motions for appointment as lead plaintiff | Applicants			8
Number of motions abandoned | Applicants			2
Number of remaining motions for appointment as lead plaintiff | Applicants			2
Number of motions filed by special situations funds | Applicants			1
Number of motions filed by municipal employees retirement system | Applicants			1
Period within which lead plaintiffs can replead their claims			14 days
Employee Litigation [Abstract]
Number of filed complaints | Claim	15
Exercise price of stock options		$ 943,126
Vested shares exercisable (in shares) | shares		266,666
Term to exercise stock options			30 days
Number of complaint purport to allege claims for breach of each of separate stock option agreements | Claim			10
Loss contingency, asserting damages amount			$ 3,190,198
Loss contingency, asserting damages excess amount			3,000,000
Loss contingency, claims entitlement to recover damages amount			$ 10,000,000
Prejudgment interest rate			9.00%
Customer Concentration Risk [Member] | Customer 1 [Member]
Concentrations [Abstract]
Accounts Receivable			$ 5,930,162				7,672,845
Supplier Concentration Risk [Member] | Vendor 1 [Member]
Concentrations [Abstract]
Accounts Payable			224,500					[1]
Supplier Concentration Risk [Member] | Vendor 2 [Member]
Concentrations [Abstract]
Accounts Payable			$ 164,983				$ 353,097
Maximum [Member]
Benefit Plan [Abstract]
Employee contribution subject to employer matching contribution			5.00%
Employer matching contribution			2.00%
Sales [Member] | Customer Concentration Risk [Member] | Customer 1 [Member]
Concentrations [Abstract]
Net product revenue			$ 11,856,024		[1]
Percentage of product sales			64.00%		[1]
Purchases [Member] | Supplier Concentration Risk [Member] | Vendor 1 [Member]
Concentrations [Abstract]
Percentage of product sales			34.00%		[1]
Purchases			$ 2,323,605		[1]
Purchases [Member] | Supplier Concentration Risk [Member] | Vendor 2 [Member]
Concentrations [Abstract]
Percentage of product sales			16.00%	11.00%
Purchases			$ 1,088,251	$ 469,635

[1] In the tables above, an asterisk (*) indicates that indicates that sales, accounts receivable, purchases or accounts payable, as applicable to the tabular column, did not exceed 10% for the period indicated.